Katie Kosko

DocwireNews

Patients with severe SCD showed a clinically meaningful improvement in health-related quality of life (HRQOL) following exa-cel treatment.New data presented at the 65th ASH Annual Meeting &amp; Exposition found that patients who received exa-cel infusion for SCD felt better in six domains: physical, emotional, social/family, functional well-being, pain experience, and overall health status.Patient-reported outcomes were measured in 17 patients (aged 18-35 years) from the CLIMB SCD-121 study who were followed for at least 16 months after infusion. Investigators assessed HRQOL at baseline, six months, and 24 months.At baseline, the five-dimension EuroQol Quality of Life Scale five levels of severity (EQ-5D-5L) and EQ visual analog scale responses were lower than the US general population norm and similar to baseline scores reported for adult patients with SCD with recurrent VOCs.However, by six months after treatment, both scores showed substantial improvements and patients maintained those scores through month 24.Moreover, Functional Assessment of Cancer Therapy-General (FACT-G) scores improved in all four subscales&mdash;physical, social/family, emotional, and functional well-being&mdash;at 24 months compared with baseline scores.Patient-reported outcomes from the Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) demonstrated improvements from baseline through month 24. The ASCQ-Me subscales included the following: emotional, social, stiffness, and sleep impact.Regarding pain, the largest numerical improvement was in pain episode frequency based on ASCQ-Me pain-related subscales. At month 24, the mean change was &minus;22.8.Bone Marrow Transplant Subscale scores also improved by six months.Reference Sharma A, Frangoul H, Mapara M, et al. Improvements in health-related quality of life after exagamglogene autotemcel in patients with severe sickle cell disease. Abstract #4999. Presented at the 65th American Society of Hematology Annual Meeting &amp; Exposition; December 9-12; San Diego, California.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Health-Related Quality of Life Improvements Seen After Exagamglogene Autotemcel Infusion

Sickle Cell Disease

Patients with severe sickle cell disease had clinically meaningful improvements in health-related quality of life after receiving exagamglogene autotemcel therapy.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe